0001493152-20-022146.txt : 20201120 0001493152-20-022146.hdr.sgml : 20201120 20201120180011 ACCESSION NUMBER: 0001493152-20-022146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201120 FILED AS OF DATE: 20201120 DATE AS OF CHANGE: 20201120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rouhandeh Steven H CENTRAL INDEX KEY: 0001294343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 201333692 MAIL ADDRESS: STREET 1: C/O SCO CAPITAL PARTNERS LLC STREET 2: 1285 AVENUE OF THE AMERICAS 85TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2020-11-20 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001294343 Rouhandeh Steven H 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 1 0 1 0 Stock Option (right to buy) 1.28 2020-11-20 4 A 0 86756 A 2030-03-16 Common Stock 86756 86756 D Stock Option (right to buy) 3.20 2020-11-20 4 D 0 86756 D 2030-03-16 Common Stock 86756 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 153244 A 2030-03-16 Common Stock 153244 153244 D Stock Option (right to buy) 1.45 2020-11-20 4 D 0 153244 D 2030-03-16 Common Stock 153244 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 120000 A 2029-04-09 Common Stock 120000 120000 D Stock Option (right to buy) 7.24 2020-11-20 4 D 0 120000 D 2029-04-09 Common Stock 120000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 120000 A 2027-12-14 Common Stock 120000 120000 D Stock Option (right to buy) 16.00 2020-11-20 4 D 0 120000 D 2027-12-14 Common Stock 120000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 200000 A 2026-12-13 Common Stock 200000 200000 D Stock Option (right to buy) 4.45 2020-11-20 4 D 0 200000 D 2026-12-13 Common Stock 200000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 200000 A 2026-02-11 Common Stock 200000 200000 D Stock Option (right to buy) 2.31 2020-11-20 4 D 0 200000 D 2026-02-11 Common Stock 200000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 125000 A 2025-05-11 Common Stock 125000 125000 D Stock Option (right to buy) 7.34 2020-11-20 4 D 0 125000 D 2025-05-11 Common Stock 125000 0 D Stock Option (right to buy) 1.28 2020-11-20 4 A 0 80000 A 2024-03-07 Common Stock 80000 80000 D Stock Option (right to buy) 18.50 2020-11-20 4 D 0 80000 D 2024-03-07 Common Stock 80000 0 D The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. The options granted on May 20, 2020, March 16, 2020, April 9, 2019, December 14, 2017, December 13, 2016, February 11, 2016, May 11, 2015 and March 17, 2014 have each been modified to reflect a lower exercise price. The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter. The options vest 25% on December 14, 2018, and in 36 equal monthly installments thereafter. The options vest 25% on December 13, 2017, and in 36 equal monthly installments thereafter. The options vest 25% on February 11, 2017, and in 36 equal monthly installments thereafter. The options vest 25% on May 11, 2016, and in 36 equal monthly installments thereafter. The options vest 25% on March 17, 2015, and in 36 equal monthly installments thereafter. /s/ Brendan M. O'Malley, as Attorney-in-fact 2020-11-20